Edwards Lifesciences
921 hedge funds and large institutions have $33.6B invested in Edwards Lifesciences in 2019 Q1 according to their latest regulatory filings, with 120 funds opening new positions, 299 increasing their positions, 335 reducing their positions, and 65 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
9% more call options, than puts
Call options by funds: $335M | Put options by funds: $308M
0.84% less ownership
Funds ownership: 254.16% → 253.32% (-0.84%)
11% less repeat investments, than reductions
Existing positions increased: 299 | Existing positions reduced: 335
Holders
921
Holding in Top 10
25
Calls
$335M
Puts
$308M
Top Buyers
| 1 | +$316M | |
| 2 | +$156M | |
| 3 | +$149M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$115M |
| 5 |
FAM
Fred Alger Management
New York
|
+$82.6M |
Top Sellers
| 1 | -$571M | |
| 2 | -$239M | |
| 3 | -$108M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$77M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$75.2M |